Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 46 of 46 entries
View as:

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Phase: N/A Priority: Normal
NCT ID: NCT05468736 Org: User:
Start: 07/22/22 End: 10/25/25 Due: 10/25/26

Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

Phase: N/A Priority: Normal
NCT ID: NCT02593071 Org: User:
Start: 10/31/15 End: 11/30/16 Due: 11/30/17

Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01072799 Org: User:
Start: 10/31/09 End: 03/31/12 Due: 03/31/13

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2

Phase: N/A Priority: Normal
NCT ID: NCT01596725 Org: User:
Start: 05/31/12 End: 08/31/13 Due: 08/31/14

Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Variant in Adults

Phase: N/A Priority: Normal
NCT ID: NCT05029856 Org: User:
Start: 02/04/22 End: 08/31/22 Due: 08/31/23

Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT03658629 Org: User:
Start: 09/24/18 End: 04/26/19 Due: 04/26/20

A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT02608502 Org: User:
Start: 11/30/15 End: 12/31/16 Due: 12/31/17

A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT02296463 Org: User:
Start: 11/30/14 End: 04/30/16 Due: 04/30/17

Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01290419 Org: User:
Start: 12/31/10 End: 12/31/11 Due: 12/31/12

Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)

Phase: N/A Priority: Normal
NCT ID: NCT00903552 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT03026348 Org: User:
Start: 01/31/17 End: 05/18/18 Due: 05/18/19

Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT01014806 Org: User:
Start: 11/30/09 End: 05/31/10 Due: 05/31/11

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02370589 Org: User:
Start: 02/28/15 End: 04/30/16 Due: 04/30/17

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Phase: N/A Priority: Normal
NCT ID: NCT02624947 Org: User:
Start: 12/31/15 End: 07/12/19 Due: 07/12/20

A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT05112848 Org: User:
Start: 02/28/22 End: 11/30/22 Due: 11/30/23

A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT06291857 Org: User:
Start: 12/09/24 End: 02/24/26 Due: 02/24/27

Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00754455 Org: User:
Start: 09/30/08 End: 03/31/09 Due: 03/31/10

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT04961541 Org: User:
Start: 09/08/21 End: 04/22/22 Due: 04/22/23

Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States

Phase: N/A Priority: Normal
NCT ID: NCT06633835 Org: User:
Start: 09/20/24 End: 08/31/25 Due: 08/31/26

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1

Phase: N/A Priority: Normal
NCT ID: NCT01594320 Org: User:
Start: 04/30/12 End: 08/31/13 Due: 08/31/14

A Strain Change Study for SARS-CoV-2 rS Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT06409663 Org: User:
Start: 10/14/24 End: 06/20/25 Due: 06/20/26